55 results
8-K
EX-3.1
PRME
Prime Medicine Inc
21 May 24
Amendments to Articles of Incorporation or Bylaws
4:03pm
the Corporation with respect to any direct or indirect compensation, reimbursement or indemnification in connection with service or action as a director that has
PRE 14A
PRME
Prime Medicine Inc
19 Apr 24
Preliminary proxy
4:07pm
. In addition, pursuant to Amendment No. 1 to the Gottesdiener Employment Agreement, Dr. Gottesdiener is entitled to reimbursement for commuting
8-K
EX-10.1
g6azrb
5 Jan 24
Departure of Directors or Certain Officers
8:15am
S-3
EX-4.5
ft0rsa0m5g4e 5g9
3 Nov 23
Shelf registration
5:23pm
S-3
EX-4.6
salvo vb96cgc5w
3 Nov 23
Shelf registration
5:23pm
S-3
wqvdwvr ikq1cl
3 Nov 23
Shelf registration
5:23pm
DEFA14A
ra3epdon
11 May 23
Additional proxy soliciting materials
8:09am
8-K
djr98 qm1y
11 May 23
Departure of Directors or Certain Officers
8:08am
8-K
EX-99.1
j1tihmz8b 07rate5gtu
11 May 23
Prime Medicine Reports First Quarter 2023 Financial Results and Provides Business Updates
8:05am
DEF 14A
1un608
28 Apr 23
Definitive proxy
8:34am
10-Q
chy0bc1sm
14 Nov 22
Quarterly report
4:46pm
424B4
m50 j6chymcr0c8qouo
21 Oct 22
Prospectus supplement with pricing info
4:47pm
S-1/A
EX-10.1
x9d4nggo
13 Oct 22
IPO registration (amended)
10:51am
S-1/A
EX-10.2
i4y0kyr c7edf4
13 Oct 22
IPO registration (amended)
10:51am